- Home
- SGBX vs DRMA Comparison
SGBX vs DRMA Comparison
Compare SGBX & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- DRMA
- Stock Information
- Founded
- SGBX 2007
- DRMA 2014
- Country
- SGBX United States
- DRMA United States
- Employees
- SGBX N/A
- DRMA N/A
- Industry
- SGBX RETAIL: Building Materials
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- DRMA Health Care
- Exchange
- SGBX Nasdaq
- DRMA Nasdaq
- Market Cap
- SGBX 2.0M
- DRMA 2.2M
- IPO Year
- SGBX 2017
- DRMA 2021
- Fundamental
- Price
- SGBX $0.58
- DRMA $1.43
- Analyst Decision
- SGBX
- DRMA Strong Buy
- Analyst Count
- SGBX 0
- DRMA 1
- Target Price
- SGBX N/A
- DRMA $6.00
- AVG Volume (30 Days)
- SGBX 915.3K
- DRMA 689.9K
- Earning Date
- SGBX 11-27-2024
- DRMA 11-13-2024
- Dividend Yield
- SGBX N/A
- DRMA N/A
- EPS Growth
- SGBX N/A
- DRMA N/A
- EPS
- SGBX N/A
- DRMA N/A
- Revenue
- SGBX $5,889,321.00
- DRMA N/A
- Revenue This Year
- SGBX $273.79
- DRMA N/A
- Revenue Next Year
- SGBX $39.31
- DRMA N/A
- P/E Ratio
- SGBX N/A
- DRMA N/A
- Revenue Growth
- SGBX N/A
- DRMA N/A
- 52 Week Low
- SGBX $0.38
- DRMA $1.00
- 52 Week High
- SGBX $10.40
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- SGBX 56.23
- DRMA 62.43
- Support Level
- SGBX $0.45
- DRMA $1.29
- Resistance Level
- SGBX $0.53
- DRMA $1.37
- Average True Range (ATR)
- SGBX 0.06
- DRMA 0.11
- MACD
- SGBX 0.03
- DRMA 0.03
- Stochastic Oscillator
- SGBX 61.32
- DRMA 89.60
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.